19-7690196-C-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001220500.2(FCER2):c.691G>C(p.Glu231Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000124 in 1,613,850 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001220500.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCER2 | NM_001220500.2 | c.691G>C | p.Glu231Gln | missense_variant | Exon 10 of 11 | ENST00000597921.6 | NP_001207429.1 | |
FCER2 | NM_002002.5 | c.691G>C | p.Glu231Gln | missense_variant | Exon 10 of 11 | NP_001993.2 | ||
FCER2 | NM_001207019.3 | c.688G>C | p.Glu230Gln | missense_variant | Exon 9 of 10 | NP_001193948.2 | ||
FCER2 | XM_005272462.5 | c.691G>C | p.Glu231Gln | missense_variant | Exon 10 of 11 | XP_005272519.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152204Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000358 AC: 9AN: 251390 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.000133 AC: 194AN: 1461646Hom.: 0 Cov.: 32 AF XY: 0.000142 AC XY: 103AN XY: 727124 show subpopulations
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74358 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.691G>C (p.E231Q) alteration is located in exon 10 (coding exon 9) of the FCER2 gene. This alteration results from a G to C substitution at nucleotide position 691, causing the glutamic acid (E) at amino acid position 231 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at